Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

PaperCitations, authors & open-access status

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,526 citations, 2005 year and gold oa status.

1,526
Citations
2005
Year
gold
OA Status

Related on ScholarIQ

Mark G. Kris
Author
Marc Ladanyi
Author
Gregory J. Riely
Author
PLoS Medicine
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account